Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR’s Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
New mRNA vaccine could reduce the recurrence and spread of skin cancer
Newsroom account for allfrontnews - world news from nine regions.
Leave a Comment
